(Jerusalem Post) Eytan Halon - Haifa-based Pluristem has secured 50 million euros ($54 million) in financing from the EU's European Investment Bank to focus on the clinical development of a placenta-based treatment for Covid-19.
2020-04-28 00:00:00Full ArticleBACK Visit the Daily Alert Archive